Winebrenner Capital Management
PFE icon

Winebrenner Capital Management’s Pfizer PFE Stock Holding History

Winebrenner Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$211K Buy
+7,381
New +$196K 0.14% 131
2026
Q2 		– Sell
-7,512
Closed -$211K – 155
2026
Q1 		$211K Buy
+7,512
New +$200K 0.14% 129

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Winebrenner Capital Management's PFE Position: Q3 2026 in Review

Winebrenner Capital Management opened a new position in Pfizer (PFE) in Q3 2026: 7,381 shares worth $211K. The stake represents 0.14% of the portfolio and ranks #131 among its holdings. This is a return to the name: Winebrenner Capital Management previously reported a position in PFE as recently as Q1 2026.

Winebrenner Capital Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $211K in Q1 2026. 1,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Winebrenner Capital Management held 7,381 shares of Pfizer worth $211K as of Q3 2026.
  • Pfizer was a new Winebrenner Capital Management position in Q3 2026.
  • Pfizer made up 0.14% of Winebrenner Capital Management's portfolio in Q3 2026, its #131 holding.
  • Winebrenner Capital Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Winebrenner Capital Management's Pfizer position peaked at $211K in Q1 2026.
  • 1,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Winebrenner Capital Management's 13F filing for Q3 2026, filed 7 Oct 2026.